Dow Up0.15% Nasdaq Up0.21%

Nektar Therapeutics (NKTR)

-NasdaqGS
13.72 0.13(0.96%) Sep 17, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 148,921   81,191   71,480  
Cost of Revenue38,509  30,428  21,891  
Gross Profit 110,412   50,763   49,589  
Operating Expenses
Research Development190,010  148,675  126,766  
Selling General and Administrative40,532  41,614  46,760  
Non Recurring -  1,675   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (120,130) (141,201) (123,937)
Income from Continuing Operations
Total Other Income/Expenses Net1,124  3,298  1,200  
Earnings Before Interest And Taxes(119,006)(137,903)(122,737)
Interest Expense40,762  33,546  10,223  
Income Before Tax(159,768)(171,449)(132,960)
Income Tax Expense2,245  406  1,018  
Minority Interest -   -   -  
Net Income From Continuing Ops(162,013)(171,855)(133,978)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (162,013) (171,855) (133,978)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (162,013) (171,855) (133,978)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.